Lakeisha Greenfield
Adult Health · Greenville, NCNPI 1912236548
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 480 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 49 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $4,111 and has fallen 57.9% since, to $1,731 in 2025. Among adult health clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 480 payments — averaging $31.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$2K
- Livanova USA, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$867
- SK Life Science, Inc.$645
- UCB, Inc.$584
- plus $8K from 43 others
What the payments were for
- Travel & lodging$1,0097%
- Food & beverage$14,14793%
- Education$1081%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS - Sentiva$1,300
- BRIUMVI$386
- ZEPOSIA$363
- Austedo XR$353
- NURTEC ODT$346
- NUPLAZID$340
- WATCHMAN Access System$260
- XCOPRI$240
- UPLIZNA$239
- VALTOCO$230
- AUSTEDO$209
- OCREVUS$149
- KESIMPTA$139
- EMGALITY$125
- Mavenclad$125
- Briviact$125
- VYVGART HYTRULO$117
- AJOVY$115
- VYEPTI$103
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$103
How this compares
$15,264 in reported general payments places this provider in the 95th percentile of 614 adult health providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $92,865 |
| Nurtec OdtRimegepant Sulfate | 30 | $45,544 |
| EliquisApixaban | 12 | $10,646 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $9,290 |
| Levetiracetam | 96 | $1,871 |
| Memantine Hcl | 83 | $1,741 |
| Donepezil Hcl | 127 | $1,256 |
| Pregabalin | 60 | $799 |
| Gabapentin | 68 | $777 |
| Baclofen | 46 | $738 |
| Topiramate | 33 | $221 |
| ClopidogrelClopidogrel Bisulfate | 20 | $201 |
| Duloxetine Hcl | 16 | $198 |
| Levetiracetam ErLevetiracetam | 15 | $168 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 12 | $154 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $155 | $92,86511 claims |
| PfizerNurtec Odt, Eliquis | $114 | $56,19042 claims |
| Upsher-smith Laboratories LLCTopiramate | $16 | $22133 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 614 adult health providers in North Carolina.
Other adult health in Greenville
- Felicia RichardsonGreenville$64K
- Amy HopkinsGreenville$31K
- Veronica PriceGreenville$10K
- Heather LarsenGreenville$9K
- Steffani LetchworthGreenville$8K
- Amanda StanfordGreenville$5K
- Robert DodgeRaleigh$311K
- Kimberly CampDurham$147K
- Henry VanpalaRaleigh$110K
- Jolene SpencerWashington$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.